Brand name
Sulfatrim, the original
We didn’t find a savings card or cash price from Sulfatrim’s maker. Ask the pharmacy for Sulfatrim’s cash price. With insurance, ask what your plan charges.
Generic name: sulfamethoxazole and trimethoprim
Used for: Urinary tract infections · Ear infections · Flare-ups of chronic bronchitis · Travelers' diarrhea · Shigella infection of the intestines (shigellosis) · Treating and preventing Pneumocystis pneumonia (PCP) · 5 more
Ask for the cash price
Generic sulfamethoxazole and trimethoprim
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as Sulfatrim, and the FDA requires it to work the same way.
Sulfatrim, the original
We didn’t find a savings card or cash price from Sulfatrim’s maker. Ask the pharmacy for Sulfatrim’s cash price. With insurance, ask what your plan charges.
There isn’t one.
Same active ingredient as Sulfatrim. Fillers and dyes can differ.
5 companies sell a generic of Sulfatrim that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has a dye: FD&C Red No. 40 · Made by Novitium Pharma
Product page on anipharmaceuticals.com
200 mg/5 mL / 40 mg/5 mL Pink
| Package | NDC |
|---|---|
| Bottle of 473 mL | 70954-258-10 |
Inactive ingredients: cellulose, microcrystalline, carboxymethylcellulose sodium, sorbitol, methylparaben, sodium benzoate, anhydrous citric acid, glycerin, polysorbate 80, water, saccharin sodium monohydrate, silicon dioxide, FD&C Red No. 40, starch, corn, maltodextrin, dimethicone
Has a dye: FD&C Red No. 40
Product page on aurobindousa.com
200 mg/5 mL / 40 mg/5 mL Pink
| Package | NDC |
|---|---|
| Bottle of 50 mL | 65862-496-50 |
| Bottle of 100 mL | 65862-496-01 |
| Bottle of 473 mL | 65862-496-47 |
Inactive ingredients: alcohol, carboxymethylcellulose sodium form, anhydrous citric acid, silicon dioxide, FD&C Red No. 40, glycerin, methylparaben, microcrystalline cellulose, polysorbate 80, water, saccharin sodium, sodium benzoate, sorbitol
Has dyes: FD&C Red No. 40, FD&C Yellow No. 6
200 mg/5 mL / 40 mg/5 mL Opaque pinkish orange
| Package | NDC |
|---|---|
| Bottle of 473 mL | 62135-749-47 |
800 mg/20 mL / 160 mg/20 mL Opaque pinkish orange
| Package | NDC |
|---|---|
| Box of 400 mL | 62135-873-24 |
Inactive ingredients: alcohol, methylparaben, sodium benzoate, anhydrous citric acid, FD&C Red No. 40, FD&C Yellow No. 6, glycerin, microcrystalline cellulose, polysorbate 80, water, saccharin sodium, carboxymethylcellulose sodium, trisodium citrate dihydrate, sorbitol solution
Has a dye: FD&C Red No. 40 · Made by Prasco Laboratories
200 mg/5 mL / 40 mg/5 mL Syrupy
| Package | NDC |
|---|---|
| Carton of 800 mL | 81033-012-40 |
Inactive ingredients: citric acid monohydrate, sodium benzoate, microcrystalline cellulose, methylparaben, carboxymethylcellulose sodium form, FD&C Red No. 40, saccharin sodium, glycerin, alcohol, polysorbate 80, water, sorbitol
Has a dye: FD&C Red No. 40
200 mg/5 mL / 40 mg/5 mL Pink
| Package | NDC |
|---|---|
| Bottle of 473 mL | 66993-727-57 |
Inactive ingredients: alcohol, methylparaben, sodium benzoate, carboxymethylcellulose sodium form, citric acid monohydrate, glycerin, microcrystalline cellulose, polysorbate 80, water, saccharin sodium, sorbitol, FD&C Red No. 40
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
“Before you fill my Sulfatrim, can you tell me what I’d pay for the brand and for a generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim oral suspension and other antibacterial drugs, sulfamethoxazole and trimethoprim oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy.
Urinary Tract Infections
For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and Proteus vulgaris. It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination.
Acute Otitis Media
For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. To date, there are limited data on the safety of repeated use of sulfamethoxazole and trimethoprim in pediatric patients under two years of age. Sulfamethoxazole and trimethoprim is not indicated for prophylactic or prolonged administration in otitis media at any age.
Acute Exacerbations of Chronic Bronchitis in Adults
For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of a single antimicrobial agent.
Shigellosis
For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated.
Pneumocystis Carinii Pneumonia
For the treatment of documented Pneumocystis carinii pneumonia and for prophylaxis against Pneumocystis carinii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing Pneumocystis carinii pneumonia.
Travelers' Diarrhea in Adults
For the treatment of travelers' diarrhea due to susceptible strains of enterotoxigenic E. coli.
Source: the FDA label for Sulfatrim (PAI Holdings, LLC dba PAI Pharma), March 6, 2025. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/sulfatrim/